Cardiac Pacemaker Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Description

The cardiac pacemaker market remains a critical area of focus for medical technology firms and healthcare providers. A cardiac pacemaker, a device designed to manage arrhythmias by regulating the heartbeat, has emerged as a lifeline for patients experiencing irregular heart rhythms such as tachycardia and bradycardia. Despite the growing prevalence of cardiovascular disorders, the global cardiac pacemaker market is expected to see a slight decrease, exhibiting CAGR of 3.2% during the forecast period, with an anticipated value reaching US$ 6.1 Bn by the end of 2031.

Driving Forces and Market Constraints

The market is primarily driven by the increasing prevalence of cardiovascular disorders, particularly in developed nations, alongside high disease occurrence rates in underdeveloped countries. Supportive initiatives by governments and non-government organizations, advanced diagnostics, and a favorable reimbursement scenario contribute positively to the market growth. However, challenges such as lack of awareness, high treatment costs, and the high rate of product recalls due to device malfunctioning are expected to restrain market growth over the forecast period.

Product Type and End-User Insights

The cardiac pacemaker market segments into implantable and external pacemakers, with implantable pacemakers anticipated to experience a decrease in market share in 2024. This shift is attributed to the growing preference for cardiac defibrillators over pacemakers in treating arrhythmias. Despite this, implantable pacemakers will continue to dominate the market revenue, thanks to their modality, effectiveness, and technological advancements over external models.

The market further categorizes into two major end-users: hospitals and ambulatory surgical centers, with hospitals expected to hold the highest market share. This is due to the higher rate of implant procedures performed in hospital settings, where reimbursement rates are more favorable compared to ambulatory surgical centers.

Regional Analysis and Trends

The global cardiac pacemaker market covers North America, Latin America, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA). North America held the leading position, attributed to its robust healthcare infrastructure and high prevalence of cardiovascular diseases. Latin America is poised for expansion, while APAC and MEA are projected to grow steadily.

Key Players and Competitive Analysis

The global cardiac pacemaker market is dominated by industry giants such as Medtronic, St.Jude Medical Inc., Boston Scientific Corporation, and BIOTRONIK SE & Co. KG, which collectively hold 80%-85% of the overall market share. These companies are at the forefront of product development, market consolidation initiatives, and possess significant strengths in innovation and global outreach. Their strategies and contributions are pivotal in shaping the future landscape of the cardiac pacemaker market.

Companies Covered in This Report -

BIOTRONIK SE & Co. KG
Boston Scientific Corporation
Medtronic
St. Jude Medical Inc.
LivaNova PLC.
lepumedical.com
Osypka Medical GmbH
Pacetronix.com
MEDICOWEB
Others.

Market Segmentation:

By Product

Implantable Cardiac Pacemaker
Single Chamber Pacemaker
Dual Chamber Pacemaker
Biventricular Pacemaker
External Cardiac Pacemaker
Market Attractiveness By Product

By End User

Hospitals
Ambulatory Surgical Centers
Market Attractiveness By End User

By Product

Implantable Cardiac Pacemaker
Single Chamber Pacemaker
Dual Chamber Pacemaker
Biventricular Pacemaker
External Cardiac Pacemaker

By Region

North America
Latin America
Europe
APAC
MEA

1. Executive Summary

1.1. Global Cardiac Pacemaker Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter's Five Forces Analysis
2.5. COVID-19 Impact Analysis
- 2.5.1. Supply
- 2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
- 2.7.1. World Economic Projections
2.8. PESTLE Analysis

3. Global Cardiac Pacemaker Market Outlook, 2018 - 2031

3.1. Global Cardiac Pacemaker Market Outlook, by Various Tests, Value (US$ Bn), 2018 - 2031
- 3.1.1. Key Highlights
  - 3.1.1.1. Implantable Cardiac Pacemaker
    - 3.1.1.1.1. Single Chamber Pacemaker
    - 3.1.1.1.2. Dual Chamber Pacemaker
    - 3.1.1.1.3. Biventricular Pacemaker
  - 3.1.1.2. External Cardiac Pacemaker
3.2. Global Cardiac Pacemaker Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 3.2.1. Key Highlights
  - 3.2.1.1. Hospitals
  - 3.2.1.2. Ambulatory Surgical Centres
3.3. Global Cardiac Pacemaker Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
- 3.3.1. Key Highlights
  - 3.3.1.1. North America
  - 3.3.1.2. Europe
  - 3.3.1.3. Asia Pacific
  - 3.3.1.4. Latin America
  - 3.3.1.5. Middle East & Africa

4. North America Cardiac Pacemaker Market Outlook, 2018 - 2031

4.1. North America Cardiac Pacemaker Market Outlook, by Various Tests, Value (US$ Bn), 2018 - 2031
- 4.1.1. Key Highlights
  - 4.1.1.1. Implantable Cardiac Pacemaker
    - 4.1.1.1.1. Single Chamber Pacemaker
    - 4.1.1.1.2. Dual Chamber Pacemaker
    - 4.1.1.1.3. Biventricular Pacemaker
  - 4.1.1.2. External Cardiac Pacemaker
4.2. North America Cardiac Pacemaker Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 4.2.1. Key Highlights
  - 4.2.1.1. Hospitals
  - 4.2.1.2. Ambulatory Surgical Centres
- 4.2.2. BPS Analysis/Market Attractiveness Analysis
4.3. North America Cardiac Pacemaker Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 4.3.1. Key Highlights
  - 4.3.1.1. U.S. Cardiac Pacemaker Market by Various Tests, Value (US$ Bn), 2018 - 2031
  - 4.3.1.2. U.S. Cardiac Pacemaker Market by End User, Value (US$ Bn), 2018 - 2031
  - 4.3.1.3. Canada Cardiac Pacemaker Market by Various Tests, Value (US$ Bn), 2018 - 2031
  - 4.3.1.4. Canada Cardiac Pacemaker Market by End User, Value (US$ Bn), 2018 - 2031
- 4.3.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Cardiac Pacemaker Market Outlook, 2018 - 2031

5.1. Europe Cardiac Pacemaker Market Outlook, by Various Tests, Value (US$ Bn), 2018 - 2031
- 5.1.1. Key Highlights
  - 5.1.1.1. Implantable Cardiac Pacemaker
    - 5.1.1.1.1. Single Chamber Pacemaker
    - 5.1.1.1.2. Dual Chamber Pacemaker
    - 5.1.1.1.3. Biventricular Pacemaker
  - 5.1.1.2. External Cardiac Pacemaker
5.2. Europe Cardiac Pacemaker Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 5.2.1. Key Highlights
  - 5.2.1.1. Hospitals
  - 5.2.1.2. Ambulatory Surgical Centres
- 5.2.2. BPS Analysis/Market Attractiveness Analysis
5.3. Europe Cardiac Pacemaker Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 5.3.1. Key Highlights
  - 5.3.1.1. Germany Cardiac Pacemaker Market by Various Tests, Value (US$ Bn), 2018 - 2031
  - 5.3.1.2. Germany Cardiac Pacemaker Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.3.1.3. U.K. Cardiac Pacemaker Market by Various Tests, Value (US$ Bn), 2018 - 2031
  - 5.3.1.4. U.K. Cardiac Pacemaker Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.3.1.5. France Cardiac Pacemaker Market by Various Tests, Value (US$ Bn), 2018 - 2031
  - 5.3.1.6. France Cardiac Pacemaker Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.3.1.7. Italy Cardiac Pacemaker Market by Various Tests, Value (US$ Bn), 2018 - 2031
  - 5.3.1.8. Italy Cardiac Pacemaker Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.3.1.9. Turkey Cardiac Pacemaker Market by Various Tests, Value (US$ Bn), 2018 - 2031
  - 5.3.1.10. Turkey Cardiac Pacemaker Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.3.1.11. Russia Cardiac Pacemaker Market by Various Tests, Value (US$ Bn), 2018 - 2031
  - 5.3.1.12. Russia Cardiac Pacemaker Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.3.1.13. Rest of Europe Cardiac Pacemaker Market by Various Tests, Value (US$ Bn), 2018 - 2031
  - 5.3.1.14. Rest of Europe Cardiac Pacemaker Market by End User, Value (US$ Bn), 2018 - 2031
- 5.3.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Cardiac Pacemaker Market Outlook, 2018 - 2031

6.1. Asia Pacific Cardiac Pacemaker Market Outlook, by Various Tests, Value (US$ Bn), 2018 - 2031
- 6.1.1. Key Highlights
  - 6.1.1.1. Implantable Cardiac Pacemaker
    - 6.1.1.1.1. Single Chamber Pacemaker
    - 6.1.1.1.2. Dual Chamber Pacemaker
    - 6.1.1.1.3. Biventricular Pacemaker
  - 6.1.1.2. External Cardiac Pacemaker
6.2. Asia Pacific Cardiac Pacemaker Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 6.2.1. Key Highlights
  - 6.2.1.1. Hospitals
  - 6.2.1.2. Ambulatory Surgical Centres
- 6.2.2. Others BPS Analysis/Market Attractiveness Analysis
6.3. Asia Pacific Cardiac Pacemaker Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 6.3.1. Key Highlights
  - 6.3.1.1. China Cardiac Pacemaker Market by Various Tests, Value (US$ Bn), 2018 - 2031
  - 6.3.1.2. China Cardiac Pacemaker Market by End User, Value (US$ Bn), 2018 - 2031
  - 6.3.1.3. Japan Cardiac Pacemaker Market by Various Tests, Value (US$ Bn), 2018 - 2031
  - 6.3.1.4. Japan Cardiac Pacemaker Market by End User, Value (US$ Bn), 2018 - 2031
  - 6.3.1.5. South Korea Cardiac Pacemaker Market by Various Tests, Value (US$ Bn), 2018 - 2031
  - 6.3.1.6. South Korea Cardiac Pacemaker Market by End User, Value (US$ Bn), 2018 - 2031
  - 6.3.1.7. India Cardiac Pacemaker Market by Various Tests, Value (US$ Bn), 2018 - 2031
  - 6.3.1.8. India Cardiac Pacemaker Market by End User, Value (US$ Bn), 2018 - 2031
  - 6.3.1.9. Southeast Asia Cardiac Pacemaker Market by Various Tests, Value (US$ Bn), 2018 - 2031
  - 6.3.1.10. Southeast Asia Cardiac Pacemaker Market by End User, Value (US$ Bn), 2018 - 2031
  - 6.3.1.11. Rest of Asia Pacific Cardiac Pacemaker Market by Various Tests, Value (US$ Bn), 2018 - 2031
  - 6.3.1.12. Rest of Asia Pacific Cardiac Pacemaker Market by End User, Value (US$ Bn), 2018 - 2031
- 6.3.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Cardiac Pacemaker Market Outlook, 2018 - 2031

7.1. Latin America Cardiac Pacemaker Market Outlook, by Various Tests, Value (US$ Bn), 2018 - 2031
- 7.1.1. Key Highlights
  - 7.1.1.1. Implantable Cardiac Pacemaker
    - 7.1.1.1.1. Single Chamber Pacemaker
    - 7.1.1.1.2. Dual Chamber Pacemaker
    - 7.1.1.1.3. Biventricular Pacemaker
  - 7.1.1.2. External Cardiac Pacemaker
7.2. Latin America Cardiac Pacemaker Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 7.2.1. Key Highlights
  - 7.2.1.1. Hospitals
  - 7.2.1.2. Ambulatory Surgical Centres
- 7.2.2. BPS Analysis/Market Attractiveness Analysis
7.3. Latin America Cardiac Pacemaker Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 7.3.1. Key Highlights
  - 7.3.1.1. Brazil Cardiac Pacemaker Market by Various Tests, Value (US$ Bn), 2018 - 2031
  - 7.3.1.2. Brazil Cardiac Pacemaker Market by End User, Value (US$ Bn), 2018 - 2031
  - 7.3.1.3. Mexico Cardiac Pacemaker Market by Various Tests, Value (US$ Bn), 2018 - 2031
  - 7.3.1.4. Mexico Cardiac Pacemaker Market by End User, Value (US$ Bn), 2018 - 2031
  - 7.3.1.5. Argentina Cardiac Pacemaker Market by Various Tests, Value (US$ Bn), 2018 - 2031
  - 7.3.1.6. Argentina Cardiac Pacemaker Market by End User, Value (US$ Bn), 2018 - 2031
  - 7.3.1.7. Rest of Latin America Cardiac Pacemaker Market by Various Tests, Value (US$ Bn), 2018 - 2031
  - 7.3.1.8. Rest of Latin America Cardiac Pacemaker Market by End User, Value (US$ Bn), 2018 - 2031
- 7.3.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Cardiac Pacemaker Market Outlook, 2018 - 2031

8.1. Middle East & Africa Cardiac Pacemaker Market Outlook, by Various Tests, Value (US$ Bn), 2018 - 2031
- 8.1.1. Key Highlights
  - 8.1.1.1. Implantable Cardiac Pacemaker
    - 8.1.1.1.1. Single Chamber Pacemaker
    - 8.1.1.1.2. Dual Chamber Pacemaker
    - 8.1.1.1.3. Biventricular Pacemaker
  - 8.1.1.2. External Cardiac Pacemaker
8.2. Middle East & Africa Cardiac Pacemaker Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 8.2.1. Key Highlights
  - 8.2.1.1. Hospitals
  - 8.2.1.2. Ambulatory Surgical Centres
- 8.2.2. BPS Analysis/Market Attractiveness Analysis
8.3. Middle East & Africa Cardiac Pacemaker Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 8.3.1. Key Highlights
  - 8.3.1.1. GCC Cardiac Pacemaker Market by Various Tests, Value (US$ Bn), 2018 - 2031
  - 8.3.1.2. GCC Cardiac Pacemaker Market by End User, Value (US$ Bn), 2018 - 2031
  - 8.3.1.3. South Africa Cardiac Pacemaker Market by Various Tests, Value (US$ Bn), 2018 - 2031
  - 8.3.1.4. South Africa Cardiac Pacemaker Market by End User, Value (US$ Bn), 2018 - 2031
  - 8.3.1.5. Egypt Cardiac Pacemaker Market by Various Tests, Value (US$ Bn), 2018 - 2031
  - 8.3.1.6. Egypt Cardiac Pacemaker Market by End User, Value (US$ Bn), 2018 - 2031
  - 8.3.1.7. Nigeria Cardiac Pacemaker Market by Various Tests, Value (US$ Bn), 2018 - 2031
  - 8.3.1.8. Nigeria Cardiac Pacemaker Market by End User, Value (US$ Bn), 2018 - 2031
  - 8.3.1.9. Rest of Middle East & Africa Cardiac Pacemaker Market by Various Tests, Value (US$ Bn), 2018 - 2031
  - 8.3.1.10. Rest of Middle East & Africa Cardiac Pacemaker Market by End User, Value (US$ Bn), 2018 - 2031
- 8.3.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

9.1. Product vs by End User Heatmap
9.2. Company Market Share Analysis, 2023
9.3. Competitive Dashboard
9.4. Company Profiles
- 9.4.1. BIOTRONIK SE & Co. KG
  - 9.4.1.1. Company Overview
  - 9.4.1.2. Product Portfolio
  - 9.4.1.3. Financial Overview
  - 9.4.1.4. Business Strategies and Development
- 9.4.2. Boston Scientific Corporation
  - 9.4.2.1. Company Overview
  - 9.4.2.2. Product Portfolio
  - 9.4.2.3. Financial Overview
  - 9.4.2.4. Business Strategies and Development
- 9.4.3. Medtronic
  - 9.4.3.1. Company Overview
  - 9.4.3.2. Product Portfolio
  - 9.4.3.3. Financial Overview
  - 9.4.3.4. Business Strategies and Development
- 9.4.4. St. Jude Medical Inc.
  - 9.4.4.1. Company Overview
  - 9.4.4.2. Product Portfolio
  - 9.4.4.3. Financial Overview
  - 9.4.4.4. Business Strategies and Development
- 9.4.5. LivaNova PLC.
  - 9.4.5.1. Company Overview
  - 9.4.5.2. Product Portfolio
  - 9.4.5.3. Financial Overview
  - 9.4.5.4. Business Strategies and Development
- 9.4.6. Lepumedical.com
  - 9.4.6.1. Company Overview
  - 9.4.6.2. Product Portfolio
  - 9.4.6.3. Financial Overview
  - 9.4.6.4. Business Strategies and Development
- 9.4.7. Osypka Medical GmbH
  - 9.4.7.1. Company Overview
  - 9.4.7.2. Product Portfolio
  - 9.4.7.3. Financial Overview
  - 9.4.7.4. Business Strategies and Development
- 9.4.8. Pacetronix
  - 9.4.8.1. Company Overview
  - 9.4.8.2. Product Portfolio
  - 9.4.8.3. Financial Overview
  - 9.4.8.4. Business Strategies and Development
- 9.4.9. MEDICOWEB
  - 9.4.9.1. Company Overview
  - 9.4.9.2. Product Portfolio
  - 9.4.9.3. Financial Overview
  - 9.4.9.4. Business Strategies and Development

10. Appendix

10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations